ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: House Passes appropriations Bill; Senate Markup in Late Summer; Kirschstein Acting NIH Director

July 9, 1993

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

National Dialogue plans biospecimen network

July 18, 2003

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Clinton Administration Issues Research Misconduct Policy.

December 8, 2000